Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Human Primary Cell Culture Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Primary Cells, Instruments, Reagents and Supplements, Primary Cell Culture Media, Other Consumables), By Cell Type (Human Primary Cells, Animal Primary Cells), By Application (Cell & Gene Therapy Development, Vaccine Production, Drug Discovery and Development, Cancer Research, Prenatal Diagnosis), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Human Primary Cell Culture Market size is forecast to increase from $4.58 Billion in 2026 to $11.18 Billion in 2034 at a CAGR of 11.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007717
Pages: 222 Pages

Human Platelet Lysate Market Size, Share and Growth Outlook, 2026: Analysis By Type (Heparinized, Non-Heparinized), By Application (Cell Therapy, Research, Tissue Regeneration, Immunotherapy, Cryopreservation Support), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Human Platelet Lysate Market size is forecast to increase from $430.54 Million in 2026 to $1344.77 Million in 2034 at a CAGR of 15.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007716
Pages: 227 Pages

Human Placental Protein Market Size, Share and Growth Outlook, 2026: Analysis By Type (Hydrolyzed Human Placental Protein, Human Placental Enzymes), By Application (Skin Care Products, Tumor Markers, Anti-aging Therapy, Hair Care), By End User (Cosmetics & Personal Care Companies, Pharmaceutical Companies, Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Human Placental Protein Market size is forecast to increase from $682.13 Million in 2026 to $1070.91 Million in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007715
Pages: 223 Pages

Human Papillomavirus Vaccine Market Size, Share and Growth Outlook, 2026: Analysis By Vaccine Type (Bivalent, Quadrivalent, Nonavalent), By Indication (Cervical Cancer, Anal Cancer, Penile Cancer, Oropharyngeal Cancer, Vaginal and Vulvar Cancers, Genital Warts), By Age Group (Pediatric, Adult), By Distribution Channel (Government Suppliers, Hospitals and Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Human Papillomavirus Vaccine Market size is forecast to increase from $9.35 Billion in 2026 to $18.49 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007714
Pages: 226 Pages

Human Papillomavirus (HPV) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Therapeutic Drug (Prophylactic & Therapeutic Vaccines, Immunomodulators & Interferons, Antiviral Drugs, Topical Antineoplastic Agents), By Route of Administration (Parenteral Injection, Topical , Oral Administration), By Clinical Indication (Cervical Malignancies & Dysplasia, Anal & Penile Cancer, Vulvar and Vaginal Malignancies, Genital Warts , Oropharyngeal Cancers), By Target Age Group (Pediatric & Adolescent Cohorts, Adult Cohorts ), By Distribution Channel (Hospital Pharmacies & Clinics, Government Suppliers & Public Health Providers, Retail and Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Human Papillomavirus (HPV) Therapeutics Market size is forecast to increase from $11.89 Billion in 2026 to $26.05 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007713
Pages: 229 Pages

Human Organoids Market Size, Share and Growth Outlook, 2026: Analysis By Product (Intestinal Organoids, Hepatic Organoids, Pancreatic Organoids, Neural Organoids, Kidney, Colorectal Organoids, Other Organ Models), By Offering Type (Ready-to-Use Organoids, Customizable Organoids, Organoid Kits & Assay Components, Media & Cryopreservation Reagents), By Cell Source (Induced Pluripotent Stem Cells , Adult Stem Cells , Embryonic Stem Cells ), By Application (Biomedical Research & Disease Pathology, Drug Discovery & Toxicology Testing, Cancer Research & Oncology Modeling, Regenerative Medicine & Bio-banking), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations , Academic & Research Institutes, Hospitals & Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Human Organoids Market size is forecast to increase from $1.49 Billion in 2026 to $4.43 Billion in 2034 at a CAGR of 14.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007712
Pages: 222 Pages

Human Microbiome Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Type (Live Biotherapeutic Products , Fecal Microbiota Transplant , Bacterial Consortia Transplant , Engineered Microbial Strains, Phage Therapies, Postbiotics & Microbial Metabolites), By Route of Administration (Oral , Rectal , Nasogastric), By Formulation (Capsules, Suspensions, Powders), By Target Indication (Clostridioides Difficile Infection, Inflammatory Bowel Disease , Irritable Bowel Syndrome , Oncology, Metabolic Disorders) Companies, and Country Forecast, 2021 to 2034

Global Human Microbiome Therapeutics Market size is forecast to increase from $324.39 Million in 2026 to $3100.39 Million in 2034 at a CAGR of 32.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007711
Pages: 220 Pages

Human Microbiome Market Size, Share and Growth Outlook, 2026: Analysis By Product (Drugs, Supplements , Diagnostic Tests, Medical Foods), By Application (Therapeutics, Diagnostics, Nutrition & Dietetics, Cosmetics), By Disease Area (Gastrointestinal Disorders, Metabolic Disorders, Cancer, Autoimmune & Inflammatory Diseases, Central Nervous System Disorders), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, Direct-to-Consumer) Companies, and Country Forecast, 2021 to 2034

Global Human Microbiome Market size is forecast to increase from $114.1 Million in 2026 to $880.43 Million in 2034 at a CAGR of 29.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007710
Pages: 228 Pages

Human Microbiome Manufacturing Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Strain Development & Optimization, Fermentation & Downstream Processing, Formulation & Fill, Analytical Testing & Quality Control, Microbiome Sequencing Services), By Molecule Type (Live Biotherapeutic Products , Bacterial Consortia, Engineered Microbes, FMT-derived Products), By Scale (Preclinical, Clinical Phase I, Clinical Phase III, Commercial Scale), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Human Microbiome Manufacturing Services Market size is forecast to increase from $1.86 Billion in 2026 to $6.4 Billion in 2034 at a CAGR of 16.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007709
Pages: 214 Pages

Human Metapneumovirus (hMPV) Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product & Component (Assay Kits & Reagents, Diagnostic Instruments & Hardware Platforms), By Test Type (Molecular Diagnostics , Immunodiagnostics , Viral Culture-Based Methods), By Test Modality (Standalone , Multiplex Respiratory Panels ), By Point of Care vs. Centralized (Centralized Laboratory-Based Testing, Point-of-Care ), By End-User (Hospitals & Critical Care Suites, Commercial Diagnostic Laboratories & Reference Hubs, Ambulatory Clinics & Outpatient Care Facilities, Academic & Infectious Disease Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Human Metapneumovirus (hMPV) Diagnostics Market size is forecast to increase from $677.6 Million in 2026 to $1539.19 Million in 2034 at a CAGR of 10.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007708
Pages: 220 Pages